» Articles » PMID: 22282908

Time-course of Effects of Oral Cinnarizine and Hyoscine on Task Performance

Overview
Publisher Sage Publications
Specialty Pharmacology
Date 2012 Jan 28
PMID 22282908
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Investigations into antimotion sickness drugs fall into two main categories: efficacy ('benefits') and side-effects ('costs'). This study was of the second type. Oral cinnarizine (30 mg: normal dose; and 75 mg: 2.5 x normal dose) and placebo, were investigated using a battery of automated mental, motor, physiological and other tests in twelve young healthy male volunteers. The higher cinnarizine dose level was chosen to exaggerate effects and make it easier to track them. Oral hyoscine (1.2 mg: 2 x normal dose) was employed as a positive internal control. Side-effects were almost exclusively due to hyoscine whereas cinnarizine was almost free of significant effects even at the higher dose of 75 mg. Hyoscine impaired performance 1-3 hours postdrug, whereas the effects of cinnarizine occurred approximately 5-7 hours postdrug. This paralleled the slower time-course for the protective action of cinnarizine against motion sickness noted in earlier studies. These results, taken in conjunction with previous trials, suggest that oral cinnarizine would seem less likely than hyoscine to produce unwanted decrements in performance.

Citing Articles

The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function.

Golding J, Wesnes K, Leaker B Br J Clin Pharmacol. 2018; 84(7):1535-1543.

PMID: 29522648 PMC: 6005615. DOI: 10.1111/bcp.13579.


Amelioration of the haloperidol-induced memory impairment and brain oxidative stress by cinnarizine.

Abdel-Salam O, El-Shamarka M, Salem N, El-Mosallamy A, Sleem A EXCLI J. 2016; 11:517-30.

PMID: 27540345 PMC: 4983713.


Pharmacokinetic optimisation of antiemetic therapy.

Campbell M, Bateman D Clin Pharmacokinet. 1992; 23(2):147-60.

PMID: 1355018 DOI: 10.2165/00003088-199223020-00006.